Ashwin Shah, MD
Urology · Monroe, MINPI 1710983812
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $16,024 of the $19,026 with a category attached, or 84.2%. Great Lakes Medical Services, LLC accounts for 88.6% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $9,349 and has fallen 91.1% since, to $829 in 2024.
Across 142 payments — averaging $133.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Great Lakes Medical Services, LLC$17K
- Astellas Pharma US Inc$362
- Antares Pharma, Inc.$320
- Dendreon Pharmaceuticals LLC$245
- AbbVie$222
- Tolmar Pharmaceuticals, Inc.$134
- plus $890 from 22 others
What the payments were for
- Speaking & faculty fees$8294%
- Food & beverage$2,14211%
- Education$320%
- Ownership interest$16,02484%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Great Lakes Medical Services, LLC | 13 | $16,853 |
| Astellas Pharma US Inc | 26 | $362 |
| Antares Pharma, Inc. | 19 | $320 |
| Dendreon Pharmaceuticals LLC | 10 | $245 |
| AbbVie(2 entities) | 14 | $222 |
| Tolmar Pharmaceuticals, Inc. | 10 | $134 |
| Myovant Sciences Inc. | 6 | $108 |
| Blue Earth Diagnostics | 5 | $83 |
| 180 Medical, Inc. | 3 | $74 |
| Clarus Therapeutics Inc. | 4 | $70 |
| Urovant Sciences Inc | 4 | $58 |
| Boston Scientific | 3 | $57 |
| Amgen | 4 | $55 |
| Medtronic | 3 | $54 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Johnson & Johnson | 2 | $33 |
| Neotract Inc. | 2 | $33 |
| Pfizer | 2 | $31 |
| Teleflex LLC | 1 | $26 |
| Abbott | 1 | $24 |
| Merck | 1 | $24 |
| Cook Medical LLC | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Axonics, Inc. | 1 | $18 |
| Mission Pharmacal Company | 1 | $18 |
| Coloplast | 1 | $18 |
| Convatec Inc. | 1 | $14 |
| Acerus Pharmaceuticals Corporation | 1 | $11 |
How this compares
$19,026 in reported general payments places this provider in the 85th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Monroe
- Ashok ReddySterling Heights$4.9M
- William RobertsAnn Arbor$973K
- Kenneth KernenTroy$910K
- William JohnstonLivonia$675K
- Jason HafronWest Bloomfield$490K
- Khurshid GhaniAnn Arbor$413K
- Richard BennettRoyal Oak$361K
- Ryan NelsonUtica$296K
- Casey DauwAnn Arbor$188K
- Aram LoebDetroit$112K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.